AI assistant
Sending…
Protalix BioTherapeutics, Inc. — Director's Dealing 2007
Jan 5, 2007
33807_dirs_2007-01-05_72f6cff6-e760-44b2-aaa4-1079b3f72254.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: ORTHODONTIX INC (ORTX)
CIK: 0001006281
Period of Report: 2006-12-31
Reporting Person: Almon Einat Brill (VP, Product Development)
More from Protalix BioTherapeutics, Inc.
Report Publication Announcement
2026
May 21
Interim / Quarterly Report
2026
May 13
Regulatory Filings
2026
May 13
Major Shareholding Notification
2026
Mar 30
Investor Presentation
2026
Feb 11
Regulatory Filings
2026
Jan 30
Regulatory Filings
2026
Jan 5
Director's Dealing
2025
Dec 23
Director's Dealing
2025
Nov 19
Interim / Quarterly Report
2025
Nov 13